*1 Wang, K., Ge, J., Han, W., Wang, D., Zhao, Y., Shen, Y., Chen, J., Chen, D., Wu, J., Shen, N., Zhu, S., Xue, B., & Xu, X. (2022). Risk factors for kidney stone disease recurrence: A comprehensive meta-analysis. BMC Urology, 22(1), 62. https://doi.org/10.1186/s12894-022-01017-4
*2 Torricelli, F. C. M., et al. (2020). "Epidemiology of stone disease in women." Current Opinion in Urology, 30(2), 87-92. DOI: 10.1097/MOU.0000000000000719
*3 Sakhaee, K., & Maalouf, N. M. (2020). "Metabolic Management of Uric Acid Stones." Journal of Nephrology, 33, 1191-1200. DOI: 10.1007/s40620-020-00746-3
*4 Moe, O. W. (2006). "Kidney stones: pathophysiology and medical management." The Lancet, 367(9507), 333-344. DOI: 10.1016/S0140-6736(06)68071-9